You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
偉思醫療(688580.SH)業績快報:2021年度淨利潤升23.81%至1.78億元
格隆匯 01-21 16:36

格隆匯1月21日丨偉思醫療(688580.SH)發佈2021年度業績快報,實現營業總收入4.3億元,同比增長13.66%;歸屬於母公司所有者的淨利潤1.78億元,同比增長23.81%;歸屬於母公司所有者的扣除非經常性損益的淨利潤1.50億元,同比增長16.96%;基本每股收益2.6024元。

2021年度公司實施《2021年限制性股票激勵計劃》產生的股份支付費用税後影響金額為1816.5萬元,在不考慮股份支付費用影響下,公司2021年實現歸屬於母公司所有者的淨利潤為1.96億元,同比增長36.46%。2021年歸屬於母公司所有者的扣除非經常性損益的淨利潤為1.68億元,同比增長31.11%。

2021年度公司克服新冠疫情影響,積極應對市場變化,持續加大研發投入,堅持以創新驅動發展。公司自主研發的磁刺激產品已經成為公司營收第一大品類,外骨骼康復機器人也已實現上市銷售,下一代磁刺激儀、醫美能量源設備等在研項目穩步推進中,為公司的業務發展持續注入增長新動力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account